Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Kuikui Jiang"'
Autor:
Shuqin Dai, Xingping Wu, Xuefang Huang, Jibin Li, Xi Wang, Shusen Wang, Jun Tang, Yanxia Shi, Xiaoming Xie, Fei Xu, Peng Liu, Jiajia Huang, Xinhua Xie, Xin An, Meiting Chen, Rouxi Hong, Wen Xia, Qiufan Zheng, Kuikui Jiang, Yongyi Zhong, Zhongyu Yuan, Yuanyuan Huang, Xiwen Bi, Cong Xue
Publikováno v:
Breast, Vol 78, Iss , Pp 103818- (2024)
Purpose: The limited understanding of long-term estradiol (E2) suppression poses challenges to the effectiveness of adjuvant therapy with aromatase inhibitors (AI), necessitating comprehensive serum E2 monitoring to address this issue. Therefore, our
Externí odkaz:
https://doaj.org/article/46a086553e6446878d66b4e1aac2b5cc
Autor:
Dongshao Chen, Fei Xu, Yongkui Lu, Wen Xia, Caiwen Du, Dun Xiong, Dong Song, Yanxia Shi, Zhongyu Yuan, Qiufan Zheng, Kuikui Jiang, Xin An, Cong Xue, Jiajia Huang, Xiwen Bi, Meiting Chen, Jingmin Zhang, Shusen Wang, Ruoxi Hong
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of developing metastases in the brain. However, research focusing on treatment strategies for hormonal receptor positive (HR+), HER2+ BC
Externí odkaz:
https://doaj.org/article/074a02d6944e425fbc909d21f71d3bfc
Autor:
Qianyi Lu, Hanxing Zhou, Jianwei Zhang, Kaping Lee, Limin Chen, Ruoxi Hong, Kuikui Jiang, Fei Xu, Wen Xia, Boyang Cao, Jingmin Zhang, Kang Shao, Peng Sun, Shusen Wang
Publikováno v:
Breast, Vol 76, Iss , Pp 103760- (2024)
Purpose: Pure mucinous breast cancer (PMC) is a rare histological type with a favourable prognosis. However, cases with recurrence have been reported and diagnosed in clinical practice. The mechanisms underlying PMC recurrence remain unknown. In this
Externí odkaz:
https://doaj.org/article/30084e5af62141bc862e26d2b0413927
Autor:
Kuikui Jiang, Danyang Zhou, Fei Xu, Wen Xia, Qiufan Zheng, Qianyi Lu, Rongzhen Luo, Ruoxi Hong, Shusen Wang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background We aimed to identify the relationship between the genomic characteristics and clinical outcomes of oligo-metastatic breast cancer. Methods Oligo-metastatic breast cancer diagnosed by pathology from January 2001 and August 2019 wer
Externí odkaz:
https://doaj.org/article/c0a1d2d9d04f4627b9ae8c6f15931385
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Previous studies have shown that high level of TILs in invasive lobular carcinoma (ILC) is associated with poor prognosis, contrary to that in TNBC and HER2‐positive breast cancer. Methods The densities of six immune cell marker
Externí odkaz:
https://doaj.org/article/b2bdd992fc60404ba96b0294912deb47
Autor:
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin An
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13019-13030 (2023)
Abstract Background Genetic testing plays an important role in guiding screening, diagnosis, and precision treatment of breast cancer (BC). However, the appropriate genetic testing criteria remain controversial. The current study aims to facilitate t
Externí odkaz:
https://doaj.org/article/fc398c7197174a02b07e752c8b9c66d0
Autor:
Danyang Zhou, Mei Li, Mohamed Hussein Yasin, Qianyi Lu, Jia Fu, Kuikui Jiang, Ruoxi Hong, Shusen Wang, Fei Xu
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract This study aimed to investigate the prognostic value of AR in HER2+ nonmetastatic breast invasive ductal carcinoma (IDC) and its relationship with the immune microenvironment. HER2+ nonmetastatic breast IDC patients diagnosed by pathology wh
Externí odkaz:
https://doaj.org/article/fec4abbf38d44bed9aa5ae05b7cb8401
Autor:
Ruoxi Hong, Wen Xia, Liye Wang, Kaping Lee, Qianyi Lu, Kuikui Jiang, Shengfeng Li, Jinquan Yu, Jin Wei, Weijia Tang, Danyang Zhou, Xin An, Jiajia Huang, Cong Xue, Xiwen Bi, Yanxia Shi, Zhongyu Yuan, Fei Xu, Shusen Wang
Publikováno v:
Cancer Communications, Vol 41, Iss 2, Pp 171-182 (2021)
Abstract Background The introductions of anti‐ human epidermal growth factor receptor‐2 (HER2) agents have significantly improved the treatment outcome of patients with HER2‐positive breast cancer. BAT8001 is a novel antibody‐drug conjugate t
Externí odkaz:
https://doaj.org/article/c649935ecd084e2fa0d01d0e5aac33b3
Autor:
Danyang Zhou, Kuikui Jiang, Ruoxi Hong, Qianyi Lu, Wen Xia, Mei Li, Chengyou Zheng, Qiufan Zheng, Fei Xu, Shusen Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTo assess the distribution characteristics and the prognostic value of immune infiltration in female oligometastatic breast cancer patients.MethodsWe retrospectively analyzed the clinicopathological data of oligometastatic breast cancer (OM
Externí odkaz:
https://doaj.org/article/b119a69f4d1e42b2808551a5f8a458c1
Autor:
Liye Wang, Rongzhen Luo, Qianyi Lu, Kuikui Jiang, Ruoxi Hong, Kaping Lee, Ping Zhang, Danyang Zhou, Shusen Wang, Fei Xu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionHR+/HER2− breast cancer (BC) has a much lower pathological complete response (pCR) rate to neoadjuvant chemotherapy (NAC). Therefore, to better stratify the relapse risk for HR+/HER2− non-pCR populations, it is essential to accurate i
Externí odkaz:
https://doaj.org/article/72f4700729cf48eabe348235faad7285